Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride versus dutasteride for male androgenetic alopecia
IRCT20231025059850N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in androgenetic alopecia (AGA) comparing Finasteride arm with Dutasteride arm (2 arms). Primary endpoints: Hair thickness, Number of hair and 2 more. Started Nov 2023; status: completed.
02
Drugs
finasteridedutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20231025059850N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231025059850N1.